Xu Jing Selected Research

Estrogen Receptor alpha

12/2021

Analysis of differentially expressed proteins between HER2 positive and triple negative breast cancer and their prognostic significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Jing Research Topics

Disease

16	Neoplasms (Cancer) 05/2024 - 01/2020
7	Schistosomiasis (Bilharziasis) 04/2019 - 05/2016
5	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2019
4	Breast Neoplasms (Breast Cancer) 05/2024 - 07/2019
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 11/2014
3	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 09/2021
3	Stroke (Strokes) 04/2015 - 12/2013
2	Wounds and Injuries (Trauma) 03/2024 - 05/2017
2	Inflammation (Inflammations) 02/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2023 - 05/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 09/2021
2	Carcinoma (Carcinomatosis) 01/2023 - 05/2017
2	COVID-19 12/2022 - 01/2021
2	Fibrosarcoma 01/2020 - 04/2015
2	Plague (Bubonic Plague) 04/2019 - 02/2018
2	Atherosclerosis 01/2019 - 05/2013
2	Brain Ischemia (Cerebral Ischemia) 09/2017 - 07/2014
2	Parkinson Disease (Parkinson's Disease) 04/2016 - 04/2014
1	Sarcoma (Soft Tissue Sarcoma) 05/2024
1	Lymphatic Metastasis 03/2024
1	Corneal Perforation 03/2024
1	Adenocarcinoma 11/2023
1	Myocarditis (Carditis) 02/2023
1	Fatty Liver 01/2023
1	Anemia 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Weight Loss (Weight Reduction) 12/2022
1	Atrophy 12/2022
1	Infections 12/2022
1	Body Weight (Weight, Body) 12/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Insulin Resistance 09/2021
1	Reperfusion Injury 02/2021

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2013
5	AntioxidantsIBA 01/2020 - 12/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2019
3	Long Noncoding RNAIBA 01/2022 - 09/2019
3	EnzymesIBA 09/2021 - 12/2013
3	Neuroprotective AgentsIBA 04/2016 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 05/2024 - 09/2019
2	mirabegronIBA 11/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2021
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2021
2	Interleukin-33IBA 01/2022 - 11/2021
2	AntigensIBA 11/2021 - 01/2018
2	Monoamine Oxidase (MAO)IBA 04/2019 - 02/2018
2	Therapeutic UsesIBA 05/2017 - 04/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 03/2024
1	LipidsIBA 03/2024
1	Cytochrome P-450 CYP2B1 (PROD)IBA 03/2024
1	Nylons (Nylon)IBA 03/2024
1	Circular RNAIBA 02/2024
1	Messenger RNA (mRNA)IBA 02/2024
1	AcetyltransferasesIBA 02/2024
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2023
1	salicylhydroxamic acid (SHAM)IBA 02/2023
1	Endothelial Growth FactorsIBA 01/2023
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2023
1	Pioglitazone (Actos)FDA Link 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Fibrinolysin FDA Link 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	TabletsIBA 01/2023
1	Angiopoietin-2IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	CytokinesIBA 10/2022
1	WNK Lysine-Deficient Protein Kinase 1IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	Interleukin-8B ReceptorsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2021
1	human ERBB2 proteinIBA 12/2021
1	ProteomeIBA 12/2021
1	Estrogen Receptor alphaIBA 12/2021
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	Histocompatibility Antigens Class IIBA 11/2021
1	MibefradilIBA 09/2021
1	PalmitatesIBA 09/2021
1	GlycogenIBA 09/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2021
1	Insulin (Novolin)FDA Link 09/2021
1	Cisplatin (Platino)FDA LinkGeneric 02/2021

Therapy/Procedure

7	Therapeutics 03/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 10/2018 - 12/2016
2	Immunotherapy 10/2022 - 01/2020
1	Sutures (Suture) 03/2024
1	Aftercare (After-Treatment) 01/2023
1	Transplantation 01/2023